跳至主要内容
临床试验/NCT07753239
NCT07753239尚未招募不适用

Efficacy of Oral Nutritional Supplementation Added to Usual Care in Community-dwelling Adults at Risk of Malnutrition and With Low Muscle Strength Following Acute Care

Abbott Nutrition7 个研究点 分布在 1 个国家目标入组 304 人开始时间: 2026年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
304
试验地点
7
主要终点
Change in body weight

研究概览

简要总结

The study aims to determine the effects of Oral Nutritional Supplement (ONS) added to usual care on body weight compared with usual care alone in community-dwelling adults aged 55 years and older who are at risk of malnutrition and have low muscle strength following acute care.

Participants randomized to receive either ONS twice daily for 180 days plus usual care, or usual care alone. Usual care includes individualized dietary counseling and standardized physical activity advice provided. The study will assess body weight, nutritional status, muscle strength, physical function, dietary intake, and safety outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
55 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At risk of malnutrition.
  • At the point of hospital discharge, the admission was for an acute medical illness.
  • Has low maximum handgrip strength.
  • Estimated life expectancy of more than 12 months.
  • Community ambulant.
  • No other chronic disease.
  • Able to communicate and follow instructions.
  • Able to consume food and beverages orally.
  • Willing to refrain from taking non-study oral nutritional supplements over the course of the study.
  • Able and willing to follow study procedures.

排除标准

  • Index hospitalization admission was for a surgical procedure or a stroke/myocardial infarction.
  • Diagnosed with type 1 or type 2 diabetes.
  • Has an active infectious disease.
  • Diagnosed with severe gastrointestinal disorders.
  • With severe or unstable congestive heart failure.
  • With chronic kidney disease stage 2 or higher, end-stage organ failure, or other pre-terminal condition.
  • Has an active malignancy within the past five years or currently receiving treatment for malignancy.
  • Has a severe or unstable musculoskeletal or neuromuscular disorder.
  • Unable to perform a valid handgrip strength assessment.
  • Any condition that makes the participant unsuitable for the study.
  • Currently enrolled in another clinical study.
  • Has an eating disorder, alcoholism or substance abuse.
  • Has dementia, delirium, or a significant neurological or psychiatric disorder.
  • Known allergy or intolerance to any ingredients of the study product.
  • Continuous use of ONS for 14 days prior to the baseline visit.
  • Has used herbal products, dietary supplements, or medications in the past 30 days that could affect body weight, appetite, or body composition.
  • Presence of clinically significant ascites, pleural effusion, edema, or dehydration.

研究组 & 干预措施

Feeding: Intervention

Experimental

干预措施: ONS (Dietary Supplement)

Feeding: Intervention

Experimental

干预措施: Standard of Care (SOC) (Other)

Feeding: None

Other

干预措施: Standard of Care (SOC) (Other)

结局指标

主要结局

Change in body weight

时间窗: Day 0 to Day 180

Measured in kg

次要结局

  • Change in body weight(Study Day 30, Study Day 90 and Study Day 180)
  • Body mass index (BMI)(Study Day 30, Study Day 90 and Study Day 180)
  • Calf circumference(Study Day 30, Study Day 90 and Study Day 180)
  • Mid-upper arm circumference (MUAC)(Study Day 30, Study Day 90 and Study Day 180)
  • Body composition(Study Day 30, Study Day 90 and Study Day 180)
  • Nutrition Risk(Study Day 30, Study Day 90 and Study Day 180)
  • Handgrip strength(Study Day 30, Study Day 90 and Study Day 180)
  • Short Physical Performance Battery (SPPB) total score(Study Day 30, Study Day 90 and Study Day 180)
  • Short Physical Performance Battery (SPPB) component scores(Study Day 30, Study Day 90 and Study Day 180)
  • 4-meter gait speed(Study Day 30, Study Day 90 and Study Day 180)
  • Chair stand time(Study Day 30, Study Day 90 and Study Day 180)
  • Energy, macronutrient and micronutrient intakes(Study Day 30, Study Day 90 and Study Day 180)
  • Energy, macronutrient and micronutrient adequacy(Study Day 30, Study Day 90 and Study Day 180)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Efficacy of Oral Nutritional Supplement in... | 临床试验